Navigation Links
Medbox, Inc. Comments on California Supreme Court Decision
Date:1/22/2013

HOLLYWOOD, Calif., Jan. 22, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), commented on the recent California Supreme Court decision that denied a review of a landmark medical marijuana case, which has drawn widespread attention from prosecutors and policymakers across the state.

The case stems from a 2010 prosecution of the owner of a medical marijuana dispensary in San Diego. The conviction was overturned by the Fourth District Court of Appeal, and last week the California Supreme Court decided to not review the case – effectively ending any further attempts at prosecution.

Notably, the State Supreme Court took the additional action of refusing to depublish the lower courts findings, thereby affirming the legality of medical marijuana sales in California.

"This is a clear declaration that medical marijuana is here to stay in California," according to Dr. Bruce Bedrick , CEO of Medbox, Inc. "The court has ruled that safe access to medical marijuana is a patient's right, and we support that decision. To date, while we have many machine placements in the state of California, we have taken a conservative approach to expanding our market reach due to conflicting regulations and legal opinions in the state. This recent development will give us the confidence we need to move forward in helping clients setup new clinics without the fear of criminal prosecution."

In related news, the City of San Diego effectively declared an end to their war on medical marijuana with a letter from Mayor Bob Filner ordering civil prosecutors to stop the crackdown on dispensaries.

In the letter sent to the police chief, city attorney and the city's Neighborhood C
'/>"/>

SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medbox, Inc. Unveils Customer Financing Program
2. Medbox, Inc. Finalizes Manufacturing Plans for 2013 Product Line
3. Medbox, Inc. Announced Increased Funding for Corporate Giving Program in 2013
4. Medbox, Inc. Commences Pursuit of Strategic Acquisitions
5. Medbox, Inc. Offers Guidance and Consultation To Washington State
6. Medbox, Inc. Protects Its Image as a Leader in Sensible Medication Dispensing
7. Medbox, Inc. at the Forefront of Providing Secure Medicine Dispensing Systems to Prisons
8. Medbox, Inc. To Support Referendum Overturning LA City Council Ban on Medical Marijuana Outlets
9. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
10. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
11. Novation Submits Comments to FDA in support of Unique Device Identification Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015   Mayo Clinic and ... develop the next generation of wearable biosensors designed to ... that this technology will be game-changer. These patch biosensors ... James Levine, M.D., Ph.D. , a Mayo Clinic ... inexpensive, and can be integrated into the care people ...
(Date:3/4/2015)... 4, 2015  Results of the recent study, ... MarginProbe for Intra-Operative Positive Margin Detection , were presented ... 32 nd Annual Miami Breast Cancer Conference last ... Moshe Papa , MD, FACS, Professor of Surgery at ... reports an analysis of MarginProbe,s efficiency and accuracy when ...
(Date:3/4/2015)...  Bayer HealthCare today announced that the U.S. ... company,s Biologics License Application (BLA) for BAY 81-8973, ... FDA approval of the investigational compound, proposed trade ... in children and adults. "Bayer ... hemophilia A patients who need them," said ...
Breaking Medicine Technology:Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3
... Jan. 3, 2012 Reportlinker.com announces that ... in its catalogue: Transdermal ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal ...
... 3, 2012  When the FDA removed Fen-Phen from the U.S. ... that powerful diet pills had become a thing of the ... burners sprung up almost immediately, and it wasn,t long before ... bags and medicine cabinets. Demand for these ...
Cached Medicine Technology:Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11BiphedAdrene™, Complex Phenylethylamine Provisional Plus Aggressive Thermogenic Compound, Leads Super-Powerful "Diet Pill" Comeback 2
(Date:3/5/2015)... Brunswick (PRWEB) March 05, 2015 Elandas ... validate product innovations as the company prepares to announce ... be comprised of individuals in the Life Sciences field. ... with our clients,” said Elandas CEO Ryan Roberts. “We ... a successful organization through our collaborative efforts. As we ...
(Date:3/4/2015)... (PRWEB) March 05, 2015 The ... therapeutics landscape over the past decade. The pharmaceutical ... for drug delivery in the form of liposomes ... manifold drugs with more safety and efficiency. ... could perhaps rely greatly upon the enhanced permeability ...
(Date:3/4/2015)... March 04, 2015 Ultraman Florida is ... mile swim, 261.4 mile bike, and 52.4 mile run. ... time of 24:45:45. , "This race was awesome and ... wonderful team and sponsors for supporting me through every ... 2015 had a total of 40 select participants invited ...
(Date:3/4/2015)... TROY Healthcare Solutions will be introducing TROY Secure ... of security for prescriptions, in Houston, Texas on Wednesday, ... located at 6633 Travis Street from 7 AM to ... Healthcare Solutions will host a continental breakfast. Starting at ... each hour to introduce attendees to TROY Secure Print ...
(Date:3/4/2015)... York, NY (PRWEB) March 04, 2015 ... creative, breakthrough marketing campaign called 'We Love Smokers' from ... cravings for tobacco. , "It’s important to establish ... be true to it. Our idea, 'We Love Smokers' ... leadership point of view. We created a bold tone ...
Breaking Medicine News(10 mins):Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3
... to develop a microchip sensitive enough to quickly determine ... that the disease can be detected earlier for more ... in Nature Nanotechnology heralds an era when ... innovation is an indication that the age of nanomedicine ...
... September 28, 2009 NovoCure, Ltd., a privately held ... a non-invasive portable medical device for the treatment of ... today. Key investors in this round included Pfizer Inc, ... "We are very pleased that Pfizer, Johnson & Johnson ...
... poll by the Harvard School of Public Health and The Boston ... state,s health reform legislation, which was enacted in 2006, support it. ... 13% are not sure. The level of public support for the ... they support the law in 2008 to 59% in the current ...
... CA On October 2nd, 2009, Henry Gabelnick PhD, ... prestigious Alan F. Guttmacher lecture at the 2009 ... Los Angeles, California. Reproductive Health 2009 is a ... Planned Parenthood Federation of America National Medical Committee, and ...
... ... recently named to the advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, Tenn. (PRWEB) September ... PerfectServe , a healthcare communications company. The board provides guidance on innovative ways to ...
... ... Research , ... September 28, 2009 -- Axiom Accelerated Patient Recruitment (Axiom), one of the ... messaging (SMS) services. , , , , ,"Mobile device outreach is the future of ...
Cached Medicine News:Health News:U of T researchers create microchip that can detect type and severity of cancer 2Health News:NovoCure Ltd. announces closing of financing round 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 3Health News:CONRAD executive director to give Guttmacher lecture at Reproductive Health 2009 2Health News:William Fuchs Named to PerfectServe Advisory Board 2Health News:Axiom Accelerated Patient Recruitment Rolls Out 2
... charts incorporate the slight change in the ... Sloan letters derived from the best corrected ... the ETDRS study. The original charts difficulty ... 234 eyes. In addition to the revised ...
... Cube is used to diagnose Stereo and Binocular ... of polarized glasses. The test can be ... visual attention, form and depth perception. The Stereo ... 450 seconds of arc and is ideal for ...
... "natural" Stereotest consists of three test plates(6mm, 3mm, ... in a range of 600 - 15 seconds. ... can only be detected if stereopsis is present. ... risk of the patient learning the correct answer. ...
Lumicon 48 mm red filter....
Medicine Products: